Loading…

In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice

Background Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion (Philadelphia, Pa.) Pa.), 2021-03, Vol.61 (3), p.687-691
Main Authors: Poston, Jacqueline N., Jash, Arijita, Hannan, Lindsay M., Hay, Ariel M., Usaneerungrueng, Chomkan, Howie, Heather L., Kapp, Linda M., Zimring, James C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293
cites cdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293
container_end_page 691
container_issue 3
container_start_page 687
container_title Transfusion (Philadelphia, Pa.)
container_volume 61
creator Poston, Jacqueline N.
Jash, Arijita
Hannan, Lindsay M.
Hay, Ariel M.
Usaneerungrueng, Chomkan
Howie, Heather L.
Kapp, Linda M.
Zimring, James C.
description Background Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations. Study Design and Methods A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens. Results No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion. Conclusions These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.
doi_str_mv 10.1111/trf.16224
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9157413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2501868305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</originalsourceid><addsrcrecordid>eNp1kUFLHDEUx0NR6qo99AvIgJf2MGtekslsLoIsagVBKPbgKcTZNxrJJNsk01Y_fbPuVqzguwRefvz5Pf6EfAY6hTJHOfZTkIyJD2QCDW9rplSzRSaUCqgBONshuyk9UEqZovCR7PAyUoCYkJsLX40ZY6jwzzKkMWKVQ2WcC8Zne4c-VctoB0zPOzsMo7dPJtvgV9zSmYwOc5Wj8akf02pvfTXYDvfJdm9cwk-bd4_8ODu9nn-rL6_OL-Ynl3UnBBc1g1s663pJJeNKti02SiDtGUMlhBKyZTMQ7YI2oGTXg1QLsWC84xJZy5EpvkeO17nL8XbARYe-yDi9sjbxUQdj9f8_3t7ru_BLK2haAbwEfNkExPBzxJT1YFOHzhmPYUyaiRaKh2CyoIdv0IcwRl_O06yhMJMzTptCfV1TXQwpRexfZIDqVWG6FKafCyvswWv7F_JfQwU4WgO_rcPH95P09fezdeRfin6fyQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2501868305</pqid></control><display><type>article</type><title>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</title><source>Wiley</source><creator>Poston, Jacqueline N. ; Jash, Arijita ; Hannan, Lindsay M. ; Hay, Ariel M. ; Usaneerungrueng, Chomkan ; Howie, Heather L. ; Kapp, Linda M. ; Zimring, James C.</creator><creatorcontrib>Poston, Jacqueline N. ; Jash, Arijita ; Hannan, Lindsay M. ; Hay, Ariel M. ; Usaneerungrueng, Chomkan ; Howie, Heather L. ; Kapp, Linda M. ; Zimring, James C.</creatorcontrib><description>Background Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations. Study Design and Methods A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens. Results No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion. Conclusions These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.</description><identifier>ISSN: 0041-1132</identifier><identifier>ISSN: 1537-2995</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/trf.16224</identifier><identifier>PMID: 33336414</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Alloantibodies ; Alloantigens ; Animal models ; Animals ; Antibodies ; Antigens ; Blood platelets ; Blood Platelets - immunology ; Breeding ; Female ; Histocompatibility antigen HLA ; HLA Antigens - immunology ; Human populations ; Independent variables ; Intrauterine exposure ; Isoantibodies - blood ; Isoantibodies - immunology ; Isoantigens - blood ; Isoantigens - immunology ; Isoimmunization ; Leukocytes ; Major histocompatibility complex ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Platelet Transfusion - adverse effects ; Platelets ; Population studies ; Pregnancy ; Thermal resistance ; Thrombocytopenia ; Transfusion ; Transplantation</subject><ispartof>Transfusion (Philadelphia, Pa.), 2021-03, Vol.61 (3), p.687-691</ispartof><rights>2020 AABB</rights><rights>2020 AABB.</rights><rights>2021 AABB</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</citedby><cites>FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</cites><orcidid>0000-0003-2431-5106 ; 0000-0002-1063-4010</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33336414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poston, Jacqueline N.</creatorcontrib><creatorcontrib>Jash, Arijita</creatorcontrib><creatorcontrib>Hannan, Lindsay M.</creatorcontrib><creatorcontrib>Hay, Ariel M.</creatorcontrib><creatorcontrib>Usaneerungrueng, Chomkan</creatorcontrib><creatorcontrib>Howie, Heather L.</creatorcontrib><creatorcontrib>Kapp, Linda M.</creatorcontrib><creatorcontrib>Zimring, James C.</creatorcontrib><title>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>Background Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations. Study Design and Methods A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens. Results No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion. Conclusions These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.</description><subject>Alloantibodies</subject><subject>Alloantigens</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Blood platelets</subject><subject>Blood Platelets - immunology</subject><subject>Breeding</subject><subject>Female</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA Antigens - immunology</subject><subject>Human populations</subject><subject>Independent variables</subject><subject>Intrauterine exposure</subject><subject>Isoantibodies - blood</subject><subject>Isoantibodies - immunology</subject><subject>Isoantigens - blood</subject><subject>Isoantigens - immunology</subject><subject>Isoimmunization</subject><subject>Leukocytes</subject><subject>Major histocompatibility complex</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Platelet Transfusion - adverse effects</subject><subject>Platelets</subject><subject>Population studies</subject><subject>Pregnancy</subject><subject>Thermal resistance</subject><subject>Thrombocytopenia</subject><subject>Transfusion</subject><subject>Transplantation</subject><issn>0041-1132</issn><issn>1537-2995</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kUFLHDEUx0NR6qo99AvIgJf2MGtekslsLoIsagVBKPbgKcTZNxrJJNsk01Y_fbPuVqzguwRefvz5Pf6EfAY6hTJHOfZTkIyJD2QCDW9rplSzRSaUCqgBONshuyk9UEqZovCR7PAyUoCYkJsLX40ZY6jwzzKkMWKVQ2WcC8Zne4c-VctoB0zPOzsMo7dPJtvgV9zSmYwOc5Wj8akf02pvfTXYDvfJdm9cwk-bd4_8ODu9nn-rL6_OL-Ynl3UnBBc1g1s663pJJeNKti02SiDtGUMlhBKyZTMQ7YI2oGTXg1QLsWC84xJZy5EpvkeO17nL8XbARYe-yDi9sjbxUQdj9f8_3t7ru_BLK2haAbwEfNkExPBzxJT1YFOHzhmPYUyaiRaKh2CyoIdv0IcwRl_O06yhMJMzTptCfV1TXQwpRexfZIDqVWG6FKafCyvswWv7F_JfQwU4WgO_rcPH95P09fezdeRfin6fyQ</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Poston, Jacqueline N.</creator><creator>Jash, Arijita</creator><creator>Hannan, Lindsay M.</creator><creator>Hay, Ariel M.</creator><creator>Usaneerungrueng, Chomkan</creator><creator>Howie, Heather L.</creator><creator>Kapp, Linda M.</creator><creator>Zimring, James C.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2431-5106</orcidid><orcidid>https://orcid.org/0000-0002-1063-4010</orcidid></search><sort><creationdate>202103</creationdate><title>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</title><author>Poston, Jacqueline N. ; Jash, Arijita ; Hannan, Lindsay M. ; Hay, Ariel M. ; Usaneerungrueng, Chomkan ; Howie, Heather L. ; Kapp, Linda M. ; Zimring, James C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alloantibodies</topic><topic>Alloantigens</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Blood platelets</topic><topic>Blood Platelets - immunology</topic><topic>Breeding</topic><topic>Female</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA Antigens - immunology</topic><topic>Human populations</topic><topic>Independent variables</topic><topic>Intrauterine exposure</topic><topic>Isoantibodies - blood</topic><topic>Isoantibodies - immunology</topic><topic>Isoantigens - blood</topic><topic>Isoantigens - immunology</topic><topic>Isoimmunization</topic><topic>Leukocytes</topic><topic>Major histocompatibility complex</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Platelet Transfusion - adverse effects</topic><topic>Platelets</topic><topic>Population studies</topic><topic>Pregnancy</topic><topic>Thermal resistance</topic><topic>Thrombocytopenia</topic><topic>Transfusion</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poston, Jacqueline N.</creatorcontrib><creatorcontrib>Jash, Arijita</creatorcontrib><creatorcontrib>Hannan, Lindsay M.</creatorcontrib><creatorcontrib>Hay, Ariel M.</creatorcontrib><creatorcontrib>Usaneerungrueng, Chomkan</creatorcontrib><creatorcontrib>Howie, Heather L.</creatorcontrib><creatorcontrib>Kapp, Linda M.</creatorcontrib><creatorcontrib>Zimring, James C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poston, Jacqueline N.</au><au>Jash, Arijita</au><au>Hannan, Lindsay M.</au><au>Hay, Ariel M.</au><au>Usaneerungrueng, Chomkan</au><au>Howie, Heather L.</au><au>Kapp, Linda M.</au><au>Zimring, James C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2021-03</date><risdate>2021</risdate><volume>61</volume><issue>3</issue><spage>687</spage><epage>691</epage><pages>687-691</pages><issn>0041-1132</issn><issn>1537-2995</issn><eissn>1537-2995</eissn><abstract>Background Platelet transfusions remain a mainstay of treatment for many patients with thrombocytopenia, but can lead to alloantibodies to Human Leukocyte Antigens (anti‐HLA) resulting in inadequate responses to subsequent platelet transfusions (refractoriness), as well as complicate transplantation. Despite substantial decreases in alloimmunization with the implementation of leukoreduction, a significant percentage of patients still become alloimmunized following platelet transfusions. It remains unclear why some patients make anti‐HLA antibodies, but others do not make anti‐HLA antibodies even with chronic transfusion. Antecedent pregnancy correlates with risk of alloimmunization due to platelet transfusion in humans ‐ however, isolation of pregnancy as a single variable is not possible in human populations. Study Design and Methods A tractable murine model of pregnancy and transfusion was engineered by breeding C57BL/6 (H‐2b) dames with BALB/c (H‐2d) sires. After pregnancy, female mice were transfused with leukoreduced platelets from F1 (H‐2b/d) donors that expressed the same paternal major histocompatibility complex (MHC) H‐2d alloantigens as the sires. Control groups allowed isolation of pregnancy or transfusion alone as independent variables. Alloimmunization was determined by testing serum for antibodies to H‐2d MHC alloantigens. Results No alloantibodies were detected after pregnancy alone, or in response to transfusion of platelets alone; however, significant levels of alloantibodies were detected when pregnancy was followed by transfusion. Conclusions These findings isolate antecedent pregnancy as a causal contribution to increased frequencies of alloimmunization by subsequent platelet transfusion in mice and provide a platform for ongoing mechanistic investigation.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33336414</pmid><doi>10.1111/trf.16224</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-2431-5106</orcidid><orcidid>https://orcid.org/0000-0002-1063-4010</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0041-1132
ispartof Transfusion (Philadelphia, Pa.), 2021-03, Vol.61 (3), p.687-691
issn 0041-1132
1537-2995
1537-2995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9157413
source Wiley
subjects Alloantibodies
Alloantigens
Animal models
Animals
Antibodies
Antigens
Blood platelets
Blood Platelets - immunology
Breeding
Female
Histocompatibility antigen HLA
HLA Antigens - immunology
Human populations
Independent variables
Intrauterine exposure
Isoantibodies - blood
Isoantibodies - immunology
Isoantigens - blood
Isoantigens - immunology
Isoimmunization
Leukocytes
Major histocompatibility complex
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Platelet Transfusion - adverse effects
Platelets
Population studies
Pregnancy
Thermal resistance
Thrombocytopenia
Transfusion
Transplantation
title In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A56%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20utero%20exposure%20to%20alloantigens%20primes%20alloimmunization%20to%20platelet%20transfusion%20in%20mice&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Poston,%20Jacqueline%20N.&rft.date=2021-03&rft.volume=61&rft.issue=3&rft.spage=687&rft.epage=691&rft.pages=687-691&rft.issn=0041-1132&rft.eissn=1537-2995&rft_id=info:doi/10.1111/trf.16224&rft_dat=%3Cproquest_pubme%3E2501868305%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4434-21b08cf606239677e594e0f22e944946728147d05196cf169d4d23c36e273e293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2501868305&rft_id=info:pmid/33336414&rfr_iscdi=true